...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of cataract and refractive surgery >Clinical outcomes of triamcinolone-assisted anterior vitrectomy after phacoemulsification complicated by posterior capsule rupture
【24h】

Clinical outcomes of triamcinolone-assisted anterior vitrectomy after phacoemulsification complicated by posterior capsule rupture

机译：曲安奈德辅助超声乳化白内障超声乳化术并发后囊破裂的临床效果

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Purpose: To compare the clinical outcomes in patients who had triamcinolone acetate-assisted anterior vitrectomy and patients who had anterior vitrectomy without triamcinolone acetate after phacoemulsification complicated by posterior capsule rupture and vitreous loss. Setting: Arrowe Park Hospital, Wirral, United Kingdom. Design: Retrospective consecutive case note review. Methods: Consecutive case notes of patients who had anterior vitrectomy assisted by triamcinolone acetonide (triamcinolone group) or without triamcinolone acetate (no-triamcinolone group) after posterior capsule rupture between January 2007 and January 2011 were identified and examined. Data recorded at the clinic visit preoperatively and 1 day and 3 months postoperatively were collated. Information recorded on the pro forma included visual acuity, ocular comorbidities, intraocular pressure (IOP), vitreous strands in the anterior chamber, and other adverse events. Results: No statistically significant difference was found in the visual acuity or IOP between 17 patients in the triamcinolone group and 34 patients in the no-triamcinolone group at any time point. Vitreous strands in the anterior chamber were noted in 1 patient in the triamcinolone group and 7 patients in the no-triamcinolone group. Cystoid macular edema (CME) was present in 3 patients in the no-triamcinolone group, including 1 patient with vitreomacular traction. Conclusions: There was no significant increase in IOP after triamcinolone acetate-assisted anterior vitrectomy. Higher rates of CME and residual anterior chamber vitreous strands in the no-triamcinolone acetate group support the clinical use of triamcinolone acetate. Financial Disclosure: No author has a financial or proprietary interest in any material or method mentioned. ? 2012 ASCRS and ESCRS Published by Elsevier Inc.
机译：目的：比较超声乳化后并发后囊破裂和玻璃体丢失的醋酸曲安奈德辅助前玻璃体切除术和无醋酸曲安奈德的前玻璃体切除术的临床结果。地点：英国威勒尔Arrowe Park医院。设计：回顾性连续病例笔记审查。方法：确定并检查了2007年1月至2011年1月在后囊破裂后接受曲安奈德（曲安奈德组）或无醋酸曲安奈德（无曲安奈德组）辅助的前玻璃体切割患者的病例记录。收集术前，术后1天和3个月时在诊所就诊时记录的数据。备考中记录的信息包括视敏度，眼合并症，眼内压（IOP），前房玻璃体丝和其他不良事件。结果：在任何时间点，曲安奈德组的17例患者和非曲安奈德组的34例的视敏度或眼压均无统计学意义。曲安奈德组中有1例患者观察到前房的玻璃纤维束，而无曲安奈德组中有7例患者记录了前房玻璃体束。非曲安西龙组中3例存在囊性黄斑水肿（CME），包括1例玻璃体视网膜牵引患者。结论：醋酸曲安奈德辅助前玻璃体切除术后眼压没有明显增加。醋酸曲安奈德组中较高的CME率和残留的前房玻璃体纤维支持醋酸曲安奈德的临床应用。财务披露：没有任何作者对所提及的任何材料或方法有财务或专有利益。 ？ 2012年ASCRS和ESCRS，由Elsevier Inc.发行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号